Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Cilofexor in Non-Cirrhotic Primary Sclerosing Cholangitis
jRCT2080224728Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of cilofexor in Primary Sclerosing Cholangitis (PSC) (3 arms), sponsored by Gilead Sciences. Started Jun 2019; status: completed.
02
Drugs
cilofexor
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on jRCT2080224728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224728.